PET with Fluorodeoxyglucose F 18/Computed Tomography as a Staging Tool in Multiple Myeloma

CENGİZ SEVAL G., ÖZKAN E., BEKSAÇ M.

PET CLINICS, cilt.14, sa.3, ss.369-382, 2019 (ESCI) identifier identifier identifier

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 14 Sayı: 3
  • Basım Tarihi: 2019
  • Doi Numarası: 10.1016/j.cpet.2019.03.009
  • Dergi Adı: PET CLINICS
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus
  • Sayfa Sayıları: ss.369-382
  • Anahtar Kelimeler: Multiple myeloma, Staging, PET/CT, POSITRON-EMISSION-TOMOGRAPHY, BONE-MARROW ANGIOGENESIS, F-18-FDG PET/CT, FDG-PET/CT, SOLITARY PLASMACYTOMA, IMAGING TECHNIQUES, MONOCLONAL GAMMOPATHY, MANAGEMENT, GUIDELINES, DIAGNOSIS
  • Ankara Üniversitesi Adresli: Evet

Özet

In the past decade novel treatment options have dramatically prolonged the survival of patients with multiple myeloma. PET combined with computed tomography (CT) is a sensitive and reliable functional imaging tool that enables diagnosis and assessment of response to chemotherapy/radiotherapy, and combines high sensitivity in identifying both lytic lesions and extramedullary soft-tissue masses with the ability to provide reliable prognostic information in the management of patients with myeloma. This review comprises a comprehensive overview of PET with fluorodeoxyglucose F 18/CT imaging in combination with other convenient imaging procedures, and attempts at standardization with emphasis on post-therapy findings in patients with myeloma.